Business · 10/07/1997Updated: 10/17/2026 · 1 min read
FDA Approves Kensey Nash Corp.'s Angio-Seal Hemostatic Puncture Closure Device
Summary
The US Food and Drug Administration (FDA) has granted premarket approval for Kensey Nash Corp.'s Angio-SealTM Hemostatic Puncture Closure Device, following a recommendation from the Circulatory System Devices Panel, as announced on September 30, 1996.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →